首页> 外文期刊>Seminars in Arthritis and Rheumatism >Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry
【24h】

Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry

机译:在肺动脉高压评估和识别硬皮病(PHAROS)登记中通过血清自身抗体状态在系统性硬化症-肺动脉高压中的生存

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To determine the association between serum autoantibodies and survival in patients with incident systemic sclerosis (SSc)-pulmonary arterial hypertension (PAH) enrolled in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
机译:目的:确定参与硬皮病登记系统的肺动脉高压评估和结果识别的事件性系统性硬化症(SSc)-肺动脉高压(PAH)患者血清自身抗体与生存率的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号